Logo
    Home
    Daily Quiz
  • Rankings
  • The Emerging Companies 2025
    Fortune 500 India
    Most Powerful Women
    The Next 500
    Forty Under Forty
    Best B-Schools
    MNC 500
  • Profiles
  • Companies
    People
  • Business
  • Markets
  • Cryptocurrency
    IPO
    Stock Market
  • Economy
  • Personal Finance
  • Tax
    Mutual Funds
    Banking
  • Opinion
    Technology
    Auto
    Lifestyle
    Long Reads
    First Edit
    Ideas
    Buy on Amazon
    Magazine Annual Subscription
  • Archives
  • Enterprise
    Investing
    Macro
    Infographics
Logo
  • Home
    • News
      • Business
      • Markets
      • Economy
      • Personal Finance
      • Opinion
      • India
      • World
      • Technology
      • Auto
      • Lifestyle
    • Media
      • Videos
      • Short Videos
      • Visual Stories
    • Magazine
      • August 2025
      • July 2025
      • June 2025
      • May 2025
      • April 2025
      • March 2025
      • February 2025
      • January 2025
    • Rankings
      • Fortune 500 India
      • The Emerging Companies
      • Forty Under Forty
      • Most Powerful Women
      • MNC 500
      • The Next 500
      • Best B-Schools
    • Profiles
      • Companies
      • People
  • Daily Quiz
Logo
Just In
We are launching an all-new AMFI website to make data and information more accessible and visually appealing: Navneet Munot, Chairman, AMFI
Mutual funds have invested 150 billion dollars in India’s equity markets since 2021: Navneet Munot, chairman, AMFI
We are launching an all-new AMFI website to make data and information more accessible and visually appealing: Navneet Munot, Chairman, AMFI
Mutual funds have invested 150 billion dollars in India’s equity markets since 2021: Navneet Munot, chairman, AMFI

Novo Nordisk

(4 search results)

Indian doctors give big thumbs up to Ozempic and Wegovy as Novo Nordisk battles court cases in U.S.

Indian doctors give big thumbs up to Ozempic and Wegovy as Novo Nordisk battles court cases in U.S.

3 hours ago
Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; prices start at ₹17,345 a month

Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; prices start at ₹17,345 a month

Jun 24, 2025 2:28pm IST
Exclusive: Novo Nordisk bets on India as Ozempic drives $43 billion global surge

Exclusive: Novo Nordisk bets on India as Ozempic drives $43 billion global surge

Apr 14, 2025 3:52pm IST
Eli Lilly launches weight-loss drug Mounjaro in India, ahead of Novo Nordisk's Ozempic

Eli Lilly launches weight-loss drug Mounjaro in India, ahead of Novo Nordisk's Ozempic

Mar 20, 2025 10:01pm IST
HomeTopicNovo Nordisk
Logo
Follow us
Published by the RP-Sanjiv Goenka Group, Fortune India - the Indian edition of Fortune magazine - sets the benchmark for editorial excellence and thought leadership in Indian business journalism.
Rankings
  • The Emerging Companies 2025
  • Fortune 500 India
  • Most Powerful Women
  • The Next 500
  • Forty Under Forty
  • Best B-Schools
  • MNC 500
Profiles
  • Companies
  • People
Most Read Sections
  • Business
  • Markets
  • Economy
  • Personal Finance
  • Opinion
Media
  • Videos
  • Short Videos
  • Visual Stories
Magazines
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • Privacy & Cookie Policy
  • Terms of Use
  • Vision & Core Values
  • Contact Us
© 2025 Fortune India. All Rights Reserved.